Immunomodulatory properties of Lung Resident Mesenchymal Stem Cells in patients with COPD

Conclusions: We have identified a population of LR-MSC in patients with COPD and controls. These cells present abnormalities in their immunomodulatory capacity in relation COPD and current smoking.Supported in part by: FIS CP16/00039, PI15/00799, SEPAR 2015/068.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Cruz, T., Lopez-Giraldo, A., Noell, G., Agusti, A., Faner Canet, M. R. Tags: Mechanisms of Lung Injury and Repair Source Type: research